Cell therapy startup Immusoft lands deal with Takeda worth p

Cell therapy startup Immusoft lands deal with Takeda worth potentially more than $900M

Seattle-based cell therapy startup Immusoft will collaborate with pharma giant Takeda to develop treatments targeted to the central nervous system in a deal…

Related Keywords

Matthew Scholz , Sean Ainsworth , Allergan , Drug Administration , Retrosense Therapeutics ,